|
CASP8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.76117999999281E-05 |
| Normal-vs-Stage3 |
8.24773582763783E-12 |
| Normal-vs-Stage4 |
2.09929851280322E-11 |
| Stage1-vs-Stage2 |
5.981800E-01 |
| Stage1-vs-Stage3 |
8.179200E-01 |
| Stage1-vs-Stage4 |
4.858000E-01 |
| Stage2-vs-Stage3 |
5.619400E-01 |
| Stage2-vs-Stage4 |
3.671800E-01 |
| Stage3-vs-Stage4 |
6.874000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.579600E-04 |
| Normal-vs-Asian |
1.22230000010326E-07 |
| Caucasian-vs-AfricanAmerican |
1.040000E-02 |
| Caucasian-vs-Asian |
1.124020E-01 |
| AfricanAmerican-vs-Asian |
2.855800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.1094237467878E-15 |
| Male-vs-Female |
7.818400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.520800E-03 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
1.579770E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.572400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.914800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.765200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.015600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.515800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.692600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.54842999999794E-05 |
| Normal-vs-Grade 2 |
1.55431223447522E-15 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
1.73710001938332E-09 |
| Grade 1-vs-Grade 2 |
7.308400E-01 |
| Grade 1-vs-Grade 3 |
8.010200E-01 |
| Grade 1-vs-Grade 4 |
5.063800E-01 |
| Grade 2-vs-Grade 3 |
9.916200E-01 |
| Grade 2-vs-Grade 4 |
6.117600E-01 |
| Grade 3-vs-Grade 4 |
5.900200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
3.55737661550393E-12 |
| ccA subtype-vs-ccB subtype |
2.013000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
2.044300E-03 |
| N0-vs-N1 |
1.836960E-01 |
|
|
